Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS

ClinicalTrials.gov ID: NCT02525939

Public ClinicalTrials.gov record NCT02525939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 1:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS): The Dal-GenE Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A placebo-controlled, randomized, double-blind, parallel group, phase III multicenter study in subjects recently hospitalized for ACS and with the appropriate genetic profile. Subjects will provide informed consent before any study-specific procedures are performed. Subject enrollment may begin in the hospital and will continue following release from the hospital. Screening procedures may be performed at the time of the index ACS event or anytime thereafter, with the condition that randomization must occur within the mandated window (4-12 weeks after the index event). Subjects will be assessed based on their medical history. Those who are likely to qualify will undergo Genotype Assay testing to evaluate genetic determination for the presence of AA genotype.

Study identification

NCT ID
NCT02525939
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
DalCor Pharmaceuticals
Industry
Enrollment
6,147 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
45 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2016 (Actual)
Primary completion
Oct 2021 (Actual)
Completion
Oct 2021 (Actual)
Last update posted
Oct 12, 2022

2016 – 2021

United States locations

U.S. sites
122
U.S. states
41
U.S. cities
122
Facility City State ZIP Site status
Research Site Alexander City Alabama — —
Research Site Huntsville Alabama — —
Research Site Mobile Alabama — —
Research Site Cottonwood Arizona — —
Research Site Glendale Arizona — —
Research Site Jonesboro Arkansas — —
Research Site Huntington Beach California — —
Research Site San Diego California — —
Research Site Torrance California — —
Research Site Denver Colorado — —
Research Site Littleton Colorado — —
Research Site Danbury Connecticut — —
Research Site Hartford Connecticut — —
Research Site Washington D.C. District of Columbia — —
Research Site Clearwater Florida — —
Research Site Daytona Beach Florida — —
Research Site Fort Lauderdale Florida — —
Research Site Gainesville Florida — —
Research Site Homestead Florida — —
Research Site Hudson Florida — —
Research Site Jacksonville Florida — —
Research Site Largo Florida — —
Research Site Miami Florida — —
Research Site Miramar Florida — —
Research Site Orlando Florida — —
Research Site Pembroke Pines Florida — —
Research Site Pensacola Florida — —
Research Site Port Charlotte Florida — —
Research Site Safety Harbor Florida — —
Research Site Tallahassee Florida — —
Research Site Atlanta Georgia — —
Research Site Columbus Georgia — —
Research Site Covington Georgia — —
Research Site Decatur Georgia — —
Research Site Macon Georgia — —
Research Site Evanston Illinois — —
Research Site Jerseyville Illinois — —
Research Site Fort Wayne Indiana — —
Research Site Newburgh Indiana — —
Research Site West Des Moines Iowa — —
Research Site Wichita Kansas — —
Research Site Owensboro Kentucky — —
Research Site Alexandria Louisiana — —
Research Site Covington Louisiana — —
Research Site Bangor Maine — —
Research Site Biddeford Maine — —
Research Site Lewiston Maine — —
Research Site Annapolis Maryland — —
Research Site Baltimore Maryland — —
Research Site Bethesda Maryland — —
Research Site Columbia Maryland — —
Research Site Salisbury Maryland — —
Research Site Hyannis Massachusetts — —
Research Site Alpena Michigan — —
Research Site Bay City Michigan — —
Research Site Lansing Michigan — —
Research Site Midland Michigan — —
Research Site Mount Clemens Michigan — —
Research Site Muskegon Michigan — —
Research Site Saginaw Michigan — —
Research Site Saint Joseph Michigan — —
Research Site Ypsilanti Michigan — —
Research Site Coon Rapids Minnesota — —
Research Site Duluth Minnesota — —
Research Site Minneapolis Minnesota — —
Research Site Saint Cloud Minnesota — —
Research Site St Louis Missouri — —
Research Site Washington Missouri — —
Research Site Missoula Montana — —
Research Site Omaha Nebraska — —
Research Site Las Vegas Nevada — —
Research Site Bridgewater New Jersey — —
Research Site Linden New Jersey — —
Research Site Somerset New Jersey — —
Research Site Summit New Jersey — —
Research Site Albuquerque New Mexico — —
Research Site Buffalo New York — —
Research Site Johnson City New York — —
Research Site New Windsor New York — —
Research Site New York New York — —
Research Site Poughkeepsie New York — —
Research Site Asheville North Carolina — —
Research Site Greensboro North Carolina — —
Research Site Pinehurst North Carolina — —
Research Site Rocky Mount North Carolina — —
Research Site Wilmington North Carolina — —
Research Site Winston-Salem North Carolina — —
Research Site Minot North Dakota — —
Research Site Canton Ohio — —
Research Site Cincinnati Ohio — —
Research Site Columbus Ohio — —
Research Site Springfield Ohio — —
Research Site Toledo Ohio — —
Research Site Zanesville Ohio — —
Research Site Oklahoma City Oklahoma — —
Research Site Butler Pennsylvania — —
Research Site Chambersburg Pennsylvania — —
Research Site Erie Pennsylvania — —
Research Site Hershey Pennsylvania — —
Research Site Langhorne Pennsylvania — —
Research Site Philadelphia Pennsylvania — —
Research Site Wyomissing Pennsylvania — —
Research Site York Pennsylvania — —
Research Site Providence Rhode Island — —
Research Site Spartanburg South Carolina — —
Research Site Rapid City South Dakota — —
Research Site Greeneville Tennessee — —
Research Site Jackson Tennessee — —
Research Site Oak Ridge Tennessee — —
Research Site Dallas Texas — —
Research Site Houston Texas — —
Research Site Kingwood Texas — —
Research Site San Antonio Texas — —
Research Site Victoria Texas — —
Research Site Wichita Falls Texas — —
Research Site Layton Utah — —
Research Site Charlottesville Virginia — —
Research Site Norfolk Virginia — —
Research Site Virginia Beach Virginia — —
Research Site Winchester Virginia — —
Research Site Seattle Washington — —
Research Site La Crosse Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 435 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02525939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 12, 2022 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02525939 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →